Bruce Linton, the high-profile executive chairman of multi-state cannabis operator Vireo Health, invested $1 million in the Minneapolis-based company through a private placement stock offering that he organized.
Linton, who was named executive chairman of Vireo last November, acquired 1.74 million of the 13.65 million units issued in the private placement. The units consist of one share and one warrant to buy a share at CA$0.96.
All told, the company raised about $7.7 million (CA$10.5 million) through the offering.
Proceeds will be used for unspecified growth plans and general corporate purposes.
“This financing reflects the confidence of the capital markets in the potential growth of sales and margins for Vireo,” Linton said in a statement.
He added there are “significant opportunities,” for Vireo to improve operations and sales growth.
The company also said that over the past 90 days it has reduced corporate expenses by about 25% on an annualized basis.
Vireo trades on the Canadian Securities Exchange as VREO and on the U.S. over-the-counter markets as VREOF.
For analysis and in-depth looks at the investment trends and deals driving the cannabis industry forward, sign up for our premium subscription service, Investor Intelligence.
